Immunoassay for in vitro quantitative determination of H-FABP in human serum and plasma. Clinically used for the auxiliary diagnosis of acute myocardial infarction.
Immunoassay for in vitro quantitative determination of Cancer Antigen 15-3 (CA15-3) in human serum and plasma, and for clinical application in breast cancer treatment effect and prognosis observation. Breast cancer is one of the most common malignant tumors in women with high.
incidence.
Immunoassay for in vitro quantitative determination of Cancer Antigen 15-3 (CA15-3) in human serum and plasma, and for clinical application in breast cancer treatment effect and prognosis observation. Breast cancer is one of the most common malignant tumors in women with high.
incidence.
Immunoassay for in vitro quantitative determination of Human Epididymal Protein 4 eCLIA in human serum and plasma. Intend to clinically used for the monitoring of curative effect on ovarian cancer.
Immunoassay for in vitro quantitative determination of Human Epididymal Protein 4 eCLIA in human serum and plasma. Intend to clinically used for the monitoring of curative effect on ovarian cancer.
Squamous Cell Carcinoma (eCLIA) is an immunoassay reagent for in vitro quantitative determination of Squamous Cell Carcinoma (SCC) in human serum and plasma by JUNO Automatic eCLIA Analyzer to aid diagnosis of cervical cancer, non-small cell carcinoma.
Squamous Cell Carcinoma (eCLIA) is an immunoassay reagent for in vitro quantitative determination of Squamous Cell Carcinoma (SCC) in human serum and plasma by JUNO Automatic eCLIA Analyzer to aid diagnosis of cervical cancer, non-small cell carcinoma.
Pro-Gastrin-Releasing Peptide (eCLIA) is an immunoassay reagent for in vitro quantitative determination of pro-Gastrin Releasing Peptide in human serum and plasma by fully automated immunassay analyzer to aid clinical monitoring of small cell lung cancer (SCLC).
Pro-Gastrin-Releasing Peptide (eCLIA) is an immunoassay reagent for in vitro quantitative determination of pro-Gastrin Releasing Peptide in human serum and plasma by fully automated immunassay analyzer to aid clinical monitoring of small cell lung cancer (SCLC).
Immunoassay for in vitro quantitative determination of total prostate specific antigen (tPSA) in human serum or plasma, and clinically mainly used for the assisted diagnosis and differential diagnosis of prostate diseases.
